Good clinical practice is a guideline for conduct of clinical research. Even though these guidelines are available misconduct makes clinical research a highly vulnerable area to commit fraud. Fraud could be of various types and due to various reasons. Whatever the circumstances be, any fraud should be dealt with strictly and regulations should be in place to prevent its occurrence. Its the FDA job to make sure everything is up to par and its there decision on penalties and its severity.